The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Elacestrant in combination with capivasertib in patients with ER+/HER2- advanced breast cancer: Update from ELEVATE, a phase 1b/2, open-label, umbrella study.
 
Wassim McHayleh
Stock and Other Ownership Interests - Relay Therapeutics
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Natera; Stemline Therapeutics
Speakers' Bureau - Agendia; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Merck; Natera; Pfizer; Stemline Therapeutics
 
Sara Tolaney
Consulting or Advisory Role - AADi; Aktis Oncology; Ambrx; Arvinas; AstraZeneca; Avenzo Therapeutics; Bayer; BeiGene; Bicycle Therapeutics; BioNTech; Boehringer Ingelheim; Boundless Bio; Bristol-Myers Squibb; Celcuity; Circle Pharma; Corcept Therapeutics; Cullinan Oncology; Daiichi Sankyo; Denali Therapeutics; eFFECTOR Therapeutics; Eisai; Ellipses Pharma; Genentech; Immunomedics/Gilead; Jazz Pharmaceuticals; Johnson & Johnson; Launch Therapeutics; Lilly; Menarini Group; Merck; Mersana; Novartis; Olema Pharmaceuticals; Pfizer; Reveal Genomics; Samsung Bioepis; Seagen; Summit Therapeutics; Systimmune; Tempus; Zuellig Pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo; Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Menarini/Stemlin (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Arvinas; AstraZeneca; Gilead Sciences; Jazz Pharmaceuticals; Lilly; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Gilead Sciences
 
Virginia Kaklamani
Honoraria - AstraZeneca; daichi; Genentech; Gilead Sciences; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Lilly; Menarini
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Novartis; Pfizer
Research Funding - Eisai
 
Mridula George
Research Funding - Incyte; Oncolytics
Other Relationship - Oncology Learning Network
 
Aditya Bardia
Consulting or Advisory Role - Alyssum; Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Erika Hamilton
Consulting or Advisory Role - Arvinas (Inst); AstraZeneca (Inst); BeOne Medicines (Inst); BioNTech (Inst); Boehringer Ingelheim (Inst); Boundless Bio (Inst); Bristol-Myers Squibb (Inst); Circle Pharma (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Halda Therapeutics (Inst); Incyclix Bio (Inst); IQvia (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Jefferies (Inst); Johnson and Johnson (Inst); Lilly (Inst); Mersana (Inst); Novartis (Inst); Pfizer (Inst); Precede Bio (Inst); Pyxis (Inst); Samsung Bioepis (Inst); Shorla Pharma (Inst); Stemline Therapeutics (Inst); Tempus (Inst)
Research Funding - Abbvie (Inst); Accutar Biotech (Inst); Artios (Inst); Arvinas (Inst); AstraZeneca (Inst); AtlasMedx (Inst); BeiGene (Inst); BeOne Medicines (Inst); Bicycle Therapeutics (Inst); Biohaven Pharmaceuticals (Inst); BioNTech (Inst); Compugen (Inst); Cullinan Oncology (Inst); Daiichi Sankyo (Inst); Dantari (Inst); Day One Biopharmaceuticals (Inst); Duality Biologics (Inst); Ellipses Pharma (Inst); Elucida Oncology (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); Genmab (Inst); Gilead Sciences (Inst); H3 Biomedicine (Inst); Iambic Therapeutics (Inst); Immunogen (Inst); Inspirna (Inst); InventisBio (Inst); Jacobio (Inst); Jazz Pharmaceuticals (Inst); K-Group Beta (Inst); Kind Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); MabSpace Biosciences (Inst); Mabwell Bioscience (Inst); Marengo Therapeutics (Inst); MediLink Therapeutics (Inst); Merck (Inst); Mersana (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Orinove (Inst); Orum Therapeutics (Inst); Pfizer (Inst); Pionyr (Inst); Prelude Therapeutics (Inst); ProfoundBio (Inst); Regeneron (Inst); Relay Therapeutics (Inst); Rgenix (Inst); Seagen (Inst); Shattuck Labs (Inst); Simcha Therapeutics (Inst); Stemline Therapeutics (Inst); Sutro Biopharma (Inst); Systimmune (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst); TheRas (Inst); Treadwell Therapeutics (Inst); Verastem (Inst); Xadcera Biopharmaceutical (Inst); Zymeworks (Inst)
 
Nancy Chan
Consulting or Advisory Role - Daiichi Sankyo; Lilly
Research Funding - Merck
 
Vicente Valero
Honoraria - AstraZeneca; Exact Sciences
Consulting or Advisory Role - AstraZeneca; Beijing Saint Lucia Hospital Management Consulting Company; Gilead Sciences; Stemline Therapeutics
Travel, Accommodations, Expenses - Genentech/Roche
 
Anja Williams
Consulting or Advisory Role - Ellipses Pharma
 
Jo Chien
Consulting or Advisory Role - Genentech/Roche; Gilead Sciences
Research Funding - Amgen (Inst); Merck (Inst); Olema Oncology (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Pending Patent Application for “COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER”
 
Yuan Yuan
Consulting or Advisory Role - AstraZeneca; Diiachi; Genentech; Stemline Therapeutics
Speakers' Bureau - Novartis
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Paula Romero
Employment - Menarini Group
 
Faten Auriol
Employment - Menarini Group
 
Jennifer Crozier
Employment - Menarini Group
 
Tomer Wasserman
Employment - Menarini Group
 
Hope Rugo
Consulting or Advisory Role - BioNTech; Bristol Meyer; Helsinn Therapeutics; Napo Pharmaceuticals
Research Funding - Ambryx (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); Daiichi Sankyo (Inst); F. Hoffman-La Roche/Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)